22/06/2021
We are proud to announce that we have received a significant grant from the EU through their Eurostars program!
This time for our joint R&D project with Tada Medical AB. The project will concentrate on developing ReLink impregnated with antimicrobial properties.
We will combine the benefits of Tada Medical´s breakaway connector ReLink, that prevents dislodgement of the IV tube, with Amicoat´s antimicrobial peptide AMC-109 which prevents growth of bacteria, fungi and viruses. This product will focus on targeting wider applications and markets such as those for dialysis and central venous catheters.
We are extremely happy about this joint project and sharing resources and manufacturing solutions to tackle the unmet clinical needs. As an outcome, we intend to commercialise this technology and deliver significant value to healthcare providers globally.
Our sincere thanks to Katarina Hedbeck, Rebecca Stjernberg Bejhed, Robert Axelsson, Raksh*ta Singh and the wonderful team at TADA for coming together for this joint project. We also take this opportunity to thank Bernat G., N and the team at Nordic Innovators P/S who helped us with refining our project in the best possible way. Last but not least many thanks to our funding agency Norges forskningsråd, Eureka, and H2020 for approving funding for this project and believing in us.
